HuGE Literature Finder
Records
1
-
27
The molecular characteristics of high-grade gastroenteropancreatic neuroendocrine neoplasms. Endocrine-related cancer 2021 Oct . Venizelos Andreas, Elvebakken Hege, Perren Aurel, Nikolaienko Oleksii, Deng Wei, Lothe Inger Marie B, Couvelard Anne, Hjortland Geir Olav, Sundlöv Anna, Svensson Johanna B, Garresori Harrish, Kersten Christian, Hofsli Eva, Detlefsen Sonke, Krogh Merete, Sorbye Halfdan, Knappskog Sti |
Genetic alterations in squamous cell lung cancer associated with idiopathic pulmonary fibrosis. International journal of cancer 2021 Feb . Hata Atsushi, Nakajima Takahiro, Matsusaka Keisuke, Fukuyo Masaki, Nakayama Manabu, Morimoto Junichi, Ito Yuki, Yamamoto Takayoshi, Sakairi Yuichi, Rahmutulla Bahityar, Ota Satoshi, Wada Hironobu, Suzuki Hidemi, Iwata Takekazu, Matsubara Hisahiro, Ohara Osamu, Yoshino Ichiro, Kaneda Atsus |
Mutation profile of non-small cell lung cancer revealed by next generation sequencing. Respiratory research 2021 Jan 22 (1): 3. Chang Ya-Sian, Tu Siang-Jyun, Chen Yu-Chia, Liu Ting-Yuan, Lee Ya-Ting, Yen Ju-Chen, Fang Hsin-Yuan, Chang Jan-Gow |
Clinicopathological and prognostic impact of somatic mutations in Chinese patients with clear cell renal cell carcinoma. Translational andrology and urology 2020 Dec 9 (6): 2751-2763. Bi Hai, Yin Jipeng, Zhou Lang, Wu Yaqian, Ge Liyuan, Lu Min, Liu Lei, Zhang Hongxian, Zhao Yongzhe, Liu Cheng, Ma Lul |
Sharing the initial experience of pan-cancer panel analysis in high-risk renal cell carcinoma in the Korean population. BMC urology 2020 Aug 20 (1): 125. Suh Jungyo, Jeong Chang Wook, Choi Seongmin, Ku Ja Hyeon, Kim Hyeon Hoe, Kim Kwangsoo, Kwak Che |
Mutations and Response to Rapalogs in Patients with Metastatic Renal Cell Carcinoma. Molecular cancer therapeutics 2019 Oct . Nassar Amin H, Hamieh Lana, Gray Kathryn P, Thorner Aaron R, Fay Andre P, Lasseter Kathryn D, Abou Alaiwi Sarah, Nuzzo Pier Vitale, Flippot Ronan, Krajewski Katherine M, Signoretti Sabina, Choueiri Toni K, Kwiatkowski David |
SETD2, GIGYF2, FGFR3, BCR, KMT2C, and TSC2 as candidate genes for differentiating multilocular cystic renal neoplasm of low malignant potential from clear cell renal cell carcinoma with cystic change. Investigative and clinical urology 2019 May 60 (3): 148-155. Kim Sung Han, Park Weon Seo, Chung Jins |
Genetic alteration of histone lysine methyltransferases and their significance in renal cell carcinoma. PeerJ 2019 7 e6396. Yan Libin, Zhang Yangjun, Ding Beichen, Zhou Hui, Yao Weimin, Xu H |
Molecular subtype classification of papillary renal cell cancer using miRNA expression. OncoTargets and therapy 2019 12 2311-2322. Yu Changwen, Dai Danjing, Xie Ju |
Genomically annotated risk model for advanced renal-cell carcinoma: a retrospective cohort study. The Lancet. Oncology 2018 12 19 (12): 1688-1698. Voss Martin H, Reising Albert, Cheng Yuan, Patel Parul, Marker Mahtab, Kuo Fengshen, Chan Timothy A, Choueiri Toni K, Hsieh James J, Hakimi A Ari, Motzer Robert |
Comparative Genomic Profiling of Matched Primary and Metastatic Tumors in Renal Cell Carcinoma. European urology focus 2017 Oct . Becerra Maria F, Reznik Ed, Redzematovic Almedina, Tennenbaum Daniel M, Kashan Mahyar, Ghanaat Mazyar, Casuscelli Jozefina, Manley Brandon, Jonsson Philip, DiNatale Renzo G, Blum Kyle A, Durack Jeremy C, Solomon Stephen B, Arcila Maria E, Bourque Caitlin, Socci Nick, Carlo Maria I, Lee Chung-Han, Voss Martin H, Feldman Darren R, Motzer Robert J, Coleman Jonathan A, Russo Paul, Cheng Emily H, Hakimi A Ari, Hsieh James |
Targeted sequencing-based analyses of candidate gene variants in ulcerative colitis-associated colorectal neoplasia. British journal of cancer 2017 Jun 117 (1): 136-143. Chakrabarty Sanjiban, Varghese Vinay Koshy, Sahu Pranoy, Jayaram Pradyumna, Shivakumar Bhadravathi M, Pai Cannanore Ganesh, Satyamoorthy Kapaet |
Frequent IDH2 R172 mutations in undifferentiated and poorly-differentiated sinonasal carcinomas. The Journal of pathology 2017 May . Dogan Snjezana, Chute Deborah J, Xu Bin, Ptashkin Ryan N, Chandramohan Raghu, Casanova-Murphy Jacklyn, Nafa Khedoudja, Bishop Justin A, Chiosea Simion I, Stelow Edward B, Ganly Ian, Pfister David G, Katabi Nora, Ghossein Ronald A, Berger Michael |
Genomic alterations as predictors of survival among patients within a combined cohort with clear cell renal cell carcinoma undergoing cytoreductive nephrectomy. Urologic oncology 2017 Apr . Tennenbaum Daniel M, Manley Brandon J, Zabor Emily, Becerra Maria F, Carlo Maria I, Casuscelli Jozefina, Redzematovic Almedina, Khan Nabeela, Arcila Maria E, Voss Martin H, Feldman Darren R, Motzer Robert J, Benfante Nicole E, Coleman Jonathan A, Russo Paul, Hsieh James J, Hakimi Abraham A |
Loss of SETD2, but not H3K36me3, correlates with aggressive clinicopathological features of clear cell renal cell carcinoma patients. Bioscience trends 2017 Mar . Liu Lei, Guo Renbo, Zhang Xiang, Liang Yiran, Kong Feng, Wang Jue, Xu Zhongh |
Genomic Biomarkers of a Randomized Trial Comparing First-line Everolimus and Sunitinib in Patients with Metastatic Renal Cell Carcinoma. European urology 2016 Oct . Hsieh James J, Chen David, Wang Patricia I, Marker Mahtab, Redzematovic Almedina, Chen Ying-Bei, Selcuklu S Duygu, Weinhold Nils, Bouvier Nancy, Huberman Kety H, Bhanot Umesh, Chevinsky Michael S, Patel Parul, Pinciroli Patrizia, Won Helen H, You Daoqi, Viale Agnes, Lee William, Hakimi A Ari, Berger Michael F, Socci Nicholas D, Cheng Emily H, Knox Jennifer, Voss Martin H, Voi Maurizio, Motzer Robert |
Integration of Recurrent Somatic Mutations with Clinical Outcomes: A Pooled Analysis of 1049 Patients with Clear Cell Renal Cell Carcinoma. European urology focus 2016 Jul . Manley Brandon John, Zabor Emily C, Casuscelli Jozefina, Tennenbaum Daniel M, Redzematovic Almedina, Becerra Maria F, Benfante Nicole, Sato Yusuke, Morikawa Teppei, Kume Haruki, Fukayama Masashi, Homma Yukio, Ogawa Seishi, Arcila Maria E, Voss Martin H, Feldman Darren R, Coleman Jonathan A, Reuter Victor E, Motzer Robert J, Russo Paul, Hsieh James J, Ari Hakimi |
Genomic characterization of sarcomatoid transformation in clear cell renal cell carcinoma. Proceedings of the National Academy of Sciences of the United States of America 2016 Feb . Bi Mark, Zhao Siming, Said Jonathan W, Merino Maria J, Adeniran Adebowale J, Xie Zuoquan, Nawaf Cayce B, Choi Jaehyuk, Belldegrun Arie S, Pantuck Allan J, Kluger Harriet M, Bilgüvar Kaya, Lifton Richard P, Shuch Bri |
Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma. The New England journal of medicine 2015 Nov . Linehan W Marston, Spellman Paul T, Ricketts Christopher J, Creighton Chad J, Fei Suzanne S, Davis Caleb, Wheeler David A, Murray Bradley A, Schmidt Laura, Vocke Cathy D, Peto Myron, Al Mamun Abu Amar M, Shinbrot Eve, Sethi Anurag, Brooks Samira, Rathmell W Kimryn, Brooks Angela N, Hoadley Katherine A, Robertson A Gordon, Brooks Denise, Bowlby Reanne, Sadeghi Sara, Shen Hui, Weisenberger Daniel J, Bootwalla Moiz, Baylin Stephen B, Laird Peter W, Cherniack Andrew D, Saksena Gordon, Haake Scott, Li Jun, Liang Han, Lu Yiling, Mills Gordon B, Akbani Rehan, Leiserson Mark D M, Raphael Benjamin J, Anur Pavana, Bottaro Donald, Albiges Laurence, Barnabas Nandita, Choueiri Toni K, Czerniak Bogdan, Godwin Andrew K, Hakimi A Ari, Ho Thai H, Hsieh James, Ittmann Michael, Kim William Y, Krishnan Bhavani, Merino Maria J, Shaw Kenna R Mills, Reuter Victor E, Reznik Ed, Shelley Carl S, Shuch Brian, Signoretti Sabina, Srinivasan Ramaprasad, Tamboli Pheroze, Thomas George, Tickoo Satish, Burnett Kenneth, Crain Daniel, Gardner Johanna, Lau Kevin, Mallery David, Morris Scott, Paulauskis Joseph D, Penny Robert J, Shelton Candace, Shelton W Troy, Sherman Mark, Thompson Eric, Yena Peggy, Avedon Melissa T, Bowen Jay, Gastier-Foster Julie M, Gerken Mark, Leraas Kristen M, Lichtenberg Tara M, Ramirez Nilsa C, Santos Tracie, Wise Lisa, Zmuda Erik, Demchok John A, Felau Ina, Hutter Carolyn M, Sheth Margi, Sofia Heidi J, Tarnuzzer Roy, Wang Zhining, Yang Liming, Zenklusen Jean C, Zhang Jiashan, Ayala Brenda, Baboud Julien, Chudamani Sudha, Liu Jia, Lolla Laxmi, Naresh Rashi, Pihl Todd, Sun Qiang, Wan Yunhu, Wu Ye, Ally Adrian, Balasundaram Miruna, Balu Saianand, Beroukhim Rameen, Bodenheimer Tom, Buhay Christian, Butterfield Yaron S N, Carlsen Rebecca, Carter Scott L, Chao Hsu, Chuah Eric, Clarke Amanda, Covington Kyle R, Dahdouli Mahmoud, Dewal Ninad, Dhalla Noreen, Doddapaneni Harsha V, Drummond Jennifer A, Gabriel Stacey B, Gibbs Richard A, Guin Ranabir, Hale Walker, Hawes Alicia, Hayes D Neil, Holt Robert A, Hoyle Alan P, Jefferys Stuart R, Jones Steven J M, Jones Corbin D, Kalra Divya, Kovar Christie, Lewis Lora, Li Jie, Ma Yussanne, Marra Marco A, Mayo Michael, Meng Shaowu, Meyerson Matthew, Mieczkowski Piotr A, Moore Richard A, Morton Donna, Mose Lisle E, Mungall Andrew J, Muzny Donna, Parker Joel S, Perou Charles M, Roach Jeffrey, Schein Jacqueline E, Schumacher Steven E, Shi Yan, Simons Janae V, Sipahimalani Payal, Skelly Tara, Soloway Matthew G, Sougnez Carrie, Tam Angela, Tan Donghui, Thiessen Nina, Veluvolu Umadevi, Wang Min, Wilkerson Matthew D, Wong Tina, Wu Junyuan, Xi Liu, Zhou Jane, Bedford Jason, Chen Fengju, Fu Yao, Gerstein Mark, Haussler David, Kasaian Katayoon, Lai Phillip, Ling Shiyun, Radenbaugh Amie, Van Den Berg David, Weinstein John N, Zhu Jingchun, Albert Monique, Alexopoulou Iakovina, Andersen Jeremiah J, Auman J Todd, Bartlett John, Bastacky Sheldon, Bergsten Julie, Blute Michael L, Boice Lori, Bollag Roni J, Boyd Jeff, Castle Erik, Chen Ying-Bei, Cheville John C, Curley Erin, Davies Benjamin, DeVolk April, Dhir Rajiv, Dike Laura, Eckman John, Engel Jay, Harr Jodi, Hrebinko Ronald, Huang Mei, Huelsenbeck-Dill Lori, Iacocca Mary, Jacobs Bruce, Lobis Michael, Maranchie Jodi K, McMeekin Scott, Myers Jerome, Nelson Joel, Parfitt Jeremy, Parwani Anil, Petrelli Nicholas, Rabeno Brenda, Roy Somak, Salner Andrew L, Slaton Joel, Stanton Melissa, Thompson R Houston, Thorne Leigh, Tucker Kelinda, Weinberger Paul M, Winemiller Cynthia, Zach Leigh Anne, Zuna Rosemary, |
Loss of histone H3 lysine 36 trimethylation is associated with an increased risk of renal cell carcinoma-specific death. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2015 Oct . Ho Thai H, Kapur Payal, Joseph Richard W, Serie Daniel J, Eckel-Passow Jeanette E, Tong Pan, Wang Jing, Castle Erik P, Stanton Melissa L, Cheville John C, Jonasch Eric, Brugarolas James, Parker Alexander |
Radiogenomics of clear cell renal cell carcinoma: preliminary findings of The Cancer Genome Atlas-Renal Cell Carcinoma (TCGA-RCC) Imaging Research Group. Abdominal imaging 2015 Aug 40 (6): 1684-92. Shinagare Atul B, Vikram Raghu, Jaffe Carl, Akin Oguz, Kirby Justin, Huang Erich, Freymann John, Sainani Nisha I, Sadow Cheryl A, Bathala Tharakeswara K, Rubin Daniel L, Oto Aytekin, Heller Matthew T, Surabhi Venkateswar R, Katabathina Venkat, Silverman Stuart |
PI3Kß inhibitor TGX221 selectively inhibits renal cell carcinoma cells with both VHL and SETD2 mutations and links multiple pathways. Scientific reports 2015 5 9465. Feng Chenchen, Sun Yang, Ding Guanxiong, Wu Zhong, Jiang Haowen, Wang Lujia, Ding Qiang, Wen H |
Radiogenomics of clear cell renal cell carcinoma: associations between CT imaging features and mutations. Radiology 2014 Feb 270 (2): 464-71. Karlo Christoph A, Di Paolo Pier Luigi, Chaim Joshua, Hakimi A Ari, Ostrovnaya Irina, Russo Paul, Hricak Hedvig, Motzer Robert, Hsieh James J, Akin Og |
Clinical and pathological impact of VHL, PBRM1, BAP1, SETD2, KDM6A, and JARID1c in clear cell renal cell carcinoma. Genes, chromosomes & cancer 2014 Jan 53 (1): 38-51. Gossage Lucy, Murtaza Muhammed, Slatter Andrew F, Lichtenstein Conrad P, Warren Anne, Haynes Beverley, Marass Francesco, Roberts Ian, Shanahan Susan J, Claas Andreas, Dunham Andrew, May Andrew P, Rosenfeld Nitzan, Forshew Tim, Eisen T |
Mutations of epigenetic regulatory genes are common in thymic carcinomas. Scientific reports 2014 4 7336. Wang Yisong, Thomas Anish, Lau Christopher, Rajan Arun, Zhu Yuelin, Killian J Keith, Petrini Iacopo, Pham Trung, Morrow Betsy, Zhong Xiaogang, Meltzer Paul S, Giaccone Giusep |
Adverse outcomes in clear cell renal cell carcinoma with mutations of 3p21 epigenetic regulators BAP1 and SETD2: a report by MSKCC and the KIRC TCGA research network. Clinical cancer research : an official journal of the American Association for Cancer Research 2013 Jun 19 (12): 3259-67. Hakimi A Ari, Ostrovnaya Irina, Reva Boris, Schultz Nikolaus, Chen Ying-Bei, Gonen Mithat, Liu Han, Takeda Shugaku, Voss Martin H, Tickoo Satish K, Reuter Victor E, Russo Paul, Cheng Emily H, Sander Chris, Motzer Robert J, Hsieh James J, |
Clinical and pathologic impact of select chromatin-modulating tumor suppressors in clear cell renal cell carcinoma. European urology 2012 Sep . Hakimi AA, Chen YB, Wren J, Gonen M, Abdel-Wahab O, Heguy A, Liu H, Takeda S, Tickoo SK, Reuter VE, Voss MH, Motzer RJ, Coleman JA, Cheng EH, Russo P, Hsieh JJ |
- Page last reviewed:Oct 1, 2021
- Page last updated:Jun 28, 2022
- Content source: